143 related articles for article (PubMed ID: 630211)
1. Comparison of combined and single-agent chemotherapy in non-Hodgkin's lymphoma of favourable histological type.
Lister TA; Cullen MH; Beard ME; Brearley RL; Whitehouse JM; Wrigley PF; Stansfeld AG; Sutcliffe SB; Malpas JS; Crowther D
Br Med J; 1978 Mar; 1(6112):533-7. PubMed ID: 630211
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy of malignant lymphoma.
Ong YW; Goh CN
Ann Acad Med Singap; 1981 Jul; 10(3):281-7. PubMed ID: 7332296
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy in the management of stage III/IV grade 1 non-Hodgkin's lymphomas (Report no 17).
Hayhoe FG
Clin Radiol; 1981 Sep; 32(5):547-52. PubMed ID: 7023798
[TBL] [Abstract][Full Text] [Related]
4. [Therapy of malignant non-Hodgkin's lymphoma].
Jandl H; Fuchs R
Z Gesamte Inn Med; 1979 Apr; 34(7):208-12. PubMed ID: 582641
[TBL] [Abstract][Full Text] [Related]
5. Results of combination chemotherapy of non-Hodgkin's lymphoma.
Schein PS; Chabner BA; Canellos GP; Young RD; Berard C; DeVita VT
Br J Cancer Suppl; 1975 Mar; 2():465-73. PubMed ID: 1101932
[TBL] [Abstract][Full Text] [Related]
6. Combination chemotherapy of advanced non-Hodgkin's lymphoma with adriamycin, vincristine, ifosfamide and prednisolone (AVIP): a preliminary report.
Ohnoshi T; Oka A; Hayashi K; Ueoka H; Sato M; Nishihara R; Yasuoka M; Sando Y; Tanaka T; Kimura I
Acta Med Okayama; 1982 Feb; 36(1):67-72. PubMed ID: 7064735
[TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy for advanced non-Hodgkin's lymphoma of unfavourable histology.
Lister TA; Cullen MH; Brearley RB; Beard ME; Stansfeld AG; Whitehouse JM; Wrigley PF; Ford JM; Malpas JS; Crowther D
Cancer Chemother Pharmacol; 1978; 1(2):107-12. PubMed ID: 373911
[TBL] [Abstract][Full Text] [Related]
8. [Results of cytostatic polychemotherapy in non-Hodgkin lymphomas].
Kratzer H; Hehenwarter W; Denz H; Bliem J; Tschurtschenthaler G; Nitsche D; Huber H; Michlmayr G
Wien Klin Wochenschr; 1983 Aug; 95(16):558-62. PubMed ID: 6689099
[TBL] [Abstract][Full Text] [Related]
9. [Combination chemotherapy with cyclophosphamide, adriamycin, vincristine and prednisolone (VEPA) for non-Hodgkin's lymphoma].
Saaki A; Yokomatsu Y; Kojima K; Yoshikawa T; Sannomiya Y; Tatsumi J; Hashimoto K; Park K; Kawarabayashi K; Yoshikawa C
Gan To Kagaku Ryoho; 1986 Jan; 13(1):65-9. PubMed ID: 3753642
[TBL] [Abstract][Full Text] [Related]
10. [Intermediate evaluation of a prospective study of the therapy of malignant non-Hodgkin lymphomas].
Jandl H; Franke A; Kammerer R; Spormann H
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):678-84. PubMed ID: 6172333
[No Abstract] [Full Text] [Related]
11. Chemotherapy of the non-Hodgkin's lymphomas.
Pasmantier MW; Coleman M; Silver RT
Med Clin North Am; 1976 Sep; 60(5):1043-52. PubMed ID: 59842
[No Abstract] [Full Text] [Related]
12. [Chemotherapy in non-Hodgkin's lymphomas (author's transl)].
Schmidt CG
Strahlentherapie; 1977 May; 153(5):283-92. PubMed ID: 69343
[TBL] [Abstract][Full Text] [Related]
13. Prednimustine v cyclophosphamide-vincristine-prednisolone in the treatment of non-Hodgkin's lymphoma with favorable histopathology: results of a national cancer care program in Sweden.
Cavallin-Ståhl E; Möller TR
Semin Oncol; 1986 Mar; 13(1 Suppl 1):19-22. PubMed ID: 3952518
[TBL] [Abstract][Full Text] [Related]
14. Combined drug treatment of Hodgkin's disease: remission induction, remission duration, and survival; an appraisal.
DeVita VT
Natl Cancer Inst Monogr; 1973 May; 36():373-9. PubMed ID: 4744596
[No Abstract] [Full Text] [Related]
15. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
[TBL] [Abstract][Full Text] [Related]
16. [Cyclophosphamide, adriamycin, vincristine, bleomycin and prednisolone (CHOP-Bleo) combination chemotherapy for advanced non-Hodgkin's lymphoma].
Sampi K; Honda T; Hattori M; Takayama S
Gan To Kagaku Ryoho; 1983 May; 10(5):1266-71. PubMed ID: 6191677
[TBL] [Abstract][Full Text] [Related]
17. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
18. [Sequential chemotherapy of malignant non-Hodgkin's lymphoma of high degree of malignancy in stages III and IV].
Mitrou PS; Fischer M; Bergmann L; Hübner K
Onkologie; 1982 Oct; 5(5):222-7. PubMed ID: 6760023
[TBL] [Abstract][Full Text] [Related]
19. Value of prednimustine in treating non Hodgkin's lymphomas of favourable histological type.
Klener P; Háber J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):103-8. PubMed ID: 2581855
[TBL] [Abstract][Full Text] [Related]
20. Intraperitoneal antineoplastic drug delivery: experience with a cyclophosphamide, vincristine and prednisolone protocol in cats with malignant lymphoma.
Teske E; van Lankveld AJ; Rutteman GR
Vet Comp Oncol; 2014 Mar; 12(1):37-46. PubMed ID: 22489828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
